| Schedule of Related Party Transactions |
Following is a summary of activity between
the Company and Pharma and NDM for the nine months ended December 31, 2018 and 2017. These amounts are unsecured, interest free,
and payable on demand.
| |
|
Three Months Ended
December 31, 2018
(unaudited)
($) |
|
|
Three Months Ended
December 31, 2017
(unaudited)
($) |
|
|
Nine Months Ended
December 31, 2018
(unaudited)
($) |
|
|
Nine Months Ended
December 31, 2017
(unaudited)
($) |
|
|
Year Ended
March 31, 2018
($) |
|
| Balance due from (to) Pharma and NDM at beginning of period |
|
|
(642,513 |
) |
|
|
(507,376 |
) |
|
|
(613,818 |
) |
|
|
(687,609 |
) |
|
|
(687,609 |
) |
| Amounts invoiced by Pharma to DDL, NM and TCL (1) |
|
|
(389,329 |
) |
|
|
(314,706 |
) |
|
|
(1,539,114 |
) |
|
|
(554,464 |
) |
|
|
(842,739 |
) |
| Amounts repaid by DDL to Pharma |
|
|
92,025 |
|
|
|
- |
|
|
|
1,130,755 |
|
|
|
440,266 |
|
|
|
1,096,767 |
|
| Amounts paid by DDL on behalf of Pharma |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
19,889 |
|
|
|
19,889 |
|
| Amounts received from Pharma |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(145,214 |
) |
| Foreign exchange differences |
|
|
21,023 |
|
|
|
(4,228 |
) |
|
|
103,383 |
|
|
|
(44,392 |
) |
|
|
(54,912 |
) |
| Balance due to Pharma and NDM at end of the period |
|
|
(918,794 |
) |
|
|
(826,310 |
) |
|
|
(918,794 |
) |
|
|
(826,310 |
) |
|
|
(613,818 |
) |
| |
(1) |
These amounts are included primarily in research and development expenses charged to the Company by Pharma. |
|